Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nanobody
100%
Oligomeric tau
100%
Brain Tissue
33%
Neurodegenerative Diseases
33%
Dementia with Lewy Bodies
20%
Oligomeric Forms
20%
Parkinson's Disease
13%
Early Diagnosis
13%
Misfolding
13%
Frontal Dementia
13%
Alpha-synuclein (α-syn)
13%
Tauopathy
13%
Cognitively Normal
13%
Huntington's Disease
13%
Fibrillar Aggregates
13%
Disease Progression
13%
Treatment Strategy
13%
Specific Morphologies
13%
Brain Tissue Samples
6%
Aggregate State
6%
Aggregate Structure
6%
Tau Isoforms
6%
Binding Specificity
6%
Therapeutic Target
6%
Soluble Aggregates
6%
Diagnostic Test
6%
Misfolded Proteins
6%
Protein Misfolding
6%
Aggregated Protein
6%
Antibody-based
6%
Protein Species
6%
Protein Variants
6%
Protein Aggregation
6%
Species Identification
6%
Serum Samples
6%
Cellular Stress
6%
Putative Drug Targets
6%
Accurate Diagnosis
6%
Dementia Diseases
6%
Diagnostic Strategy
6%
Phosphorylated tau
6%
Toxic Species
6%
Diagnosis Strategy
6%
Healthy Tissue
6%
Disease Onset
6%
Normal Brain
6%
Single-chain Antibody Fragment
6%
Disease Diagnosis
6%
Concentration Profile
6%
Tau Aggregates
6%
Immunoprecipitates
6%
Early Events
6%
Specificity Protein 1
6%
Stress-induced
6%
Total tau
6%
Diagnostic Targets
6%
Source Control
6%
Recombinant tau
6%
Mutant Huntingtin (mHTT)
6%
Neuroscience
Single-Domain Antibody
100%
Neurodegenerative Disorder
33%
Huntington's Disease
13%
Dementia with Lewy Bodies
13%
Parkinson's Disease
13%
Tauopathy
13%
Huntingtin
6%
Immunoprecipitation
6%
Cell Stress
6%
Protein Aggregation
6%
Beta Amyloid
6%
Single-Chain Variable Fragment
6%
Alpha-Synuclein
6%
Protein Variant
6%
Protein Misfolding
6%
Biochemistry, Genetics and Molecular Biology
Single-Domain Antibody
100%
Tau
100%